Polymyxin B Sulfate

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

50 API Suppliers, 15 USDMF, 8 CEP/COS, 2 JDMF, 2 EU WC, 2 KDMF, 19 NDC API, 25 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

12 Drugs in Development

12 Drugs in Development

FINISHED DOSAGE FORMULATIONS

178 FDF Dossiers, 96 FDA Orange Book, 36 Europe, 19 Canada, 8 South Africa, 19 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

OINTMENT;OPHTHALMIC - 0.1%;EQ 3.5MG BASE/GM;10,000 UNITS/GM, OINTMENT;TOPICAL - 400 UNITS/GM;1%;EQ 3.5MG BASE/GM;5,000 UNITS/GM **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CREAM;TOPICAL - 0.5%;EQ 3.5MG BASE/GM;10,000 UNITS/GM **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, OINTMENT;OPHTHALMIC - 400 UNITS/GM;EQ 3.5MG BASE/GM;10,000 UNITS/GM, SOLUTION/DROPS;OPHTHALMIC - 10,000 UNITS/ML;EQ 1MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 1 SPI Pharma, 5 DKSH, 8 Nanjing Well Pharmaceutical, 1 Shanghai Minbiotech, 1 Pfanstiehl, 9 Kirsch Pharma, 1 ACG Worldwide, 17 Actylis, 2 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 24 BASF, 2 CD Formulation, 10 Corel Pharma Chem, 2 Esteem Industries, 3 Finar, 9 Gangwal Chemicals, 3 Ideal Cures, 11 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 4 Microlex e.U, 2 Nanjing Bold Chemical, 2 Nippon Fine Chemical, 2 Nomisma Healthcare, 1 Novo Excipients, 1 Pluviaendo, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 5 Roquette, 17 Seppic, 1 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Sigachi Industries, 2 The Dow Chemical Company, 1 Valens Pharmachem

EXCIPIENTS BY APPLICATIONS

40 Coating Systems & Additives, 39 Topical, 35 Solubilizers, 27 Thickeners and Stabilizers, 27 Parenteral, 20 Emulsifying Agents, 16 Controlled & Modified Release, 14 Film Formers & Plasticizers, 13 Surfactant & Foaming Agents, 8 Fillers, Diluents & Binders, 8 Direct Compression, 7 Granulation, 5 Empty Capsules, 5 API Stability Enhancers, 5 Rheology Modifiers, 5 Lubricants & Glidants, 4 Co-Processed Excipients, 4 Vegetarian Capsules, 3 Taste Masking, 3 Chewable & Orodispersible Aids, 2 Coloring Agents, 1 Disintegrants & Superdisintegrants

DIGITAL CONTENT

14 News #PharmaBuzz

14 News #PharmaBuzz

GLOBAL SALES INFORMATION

26 US Medicaid Prescriptions, 1 Regulatory FDF Prices, 1 Annual Reports

MARKET PLACE

32 APIs, 7 FDF Dossiers

REF. STANDARDS & IMPURITIES

1 EDQM, 2 Others

$ Xls

Filters

Xls

USFDA APPLICATION NUMBER - 50417 / DOSAGE - OINTMENT;OPHTHALMIC - 400 UNITS/GM;EQ 3.5MG BASE/GM;10,000 UNITS/GM

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
BACITRACIN ZINC(UNII: 89Y4M234ES) (BACITRACIN - UNII:58H6RWO52I)	BACITRACIN	400[USP' in 1
NEOMYCIN SULFATE(UNII: 057Y626693) (NEOMYCIN - UNII:I16QD7X297)	NEOMYCIN	3.5mg in 1
POLYMYXIN B SULFATE(UNII: 19371312D4) (POLYMYXIN B - UNII:J2VZ07J96K)	POLYMYXIN B	10000[USP' in 1

Inactive Ingredients

Ingredient Name	A-S Medication Solutions	A-S Medication Solutions LLC	Fera Pharmaceuticals	Lake Erie Medical DBA Quality Care Products LLC	Major Pharmaceuticals	MWI	Putney, Inc.	Citron Pharma LLC
MINERAL OIL(T5L8T28FGP)
PETROLATUM(4T6H12BN9U)

Setid B9658136 C2b1 492e A9ff 8a8d4e5f5ff6 Applno 50417 Form Ointment Ophthalmic Dosage 400 Units Gm Eq 3 5mg Base Gm 10 000 Units Gm - Drug Product Composition: Polymyxin B Sulfate